FDA approvals decline but drug innovation remains strong even among small sponsors
Approvals last year included rare disease treatments, new oncology drugs, Eli Lilly’s Kisunla, and Mesoblast's Ryoncil.
Cure Today2 小时
Meet Bladder Cancer Warrior Mike and His Wife and Care Partner, Heidi
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...